Re Healthcare industry - the thing is it is only very rarely that big pharma will buy anything on market if they want a piece of the company they will either make an offer to acquire it or they will talk themselves into a placement or deal that gives them equity in the company - same goes with funds they will very rarely buy a big stake on market - it's always off market. Regulators will be the ones holding the key here though - it all rests on how they embrace PRR's data to date. ODD & Fast Track will only help with encouraging good responses.
Ann: CVac demonstrates overall survival benefit, page-43
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.5¢ |
Change
0.060(20.3%) |
Mkt cap ! $515.6M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 37.5¢ | 33.5¢ | $6.427M | 18.03M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50000 | 35.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.0¢ | 133736 | 5 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |